Our NextGen project is actively participating in the DIA Europe 2025 annual meeting, taking place from 18 to 20 March 2025 in Basel, Switzerland. DIA Global – Drug Information Organisation is partner in the NextGen project and the leading global multidisciplinary life science membership association, which drives collaboration in drug, device, and diagnostic development in pursuit of a healthier world. Every year DIA organises the largest neutral conference in the European life sciences arena. This year, the annual meeting is dedicated to transforming insights into action by bridging the gap between critical policy discussions and real-world expertise.

NextGen will seize this opportunity to present its goals, approaches, and results in developing novel AI tools for cardiovascular medicine.

The project has been invited to participate in a session on 19 March 2025, where it will showcase key project highlights.

Additionally, NextGen will host a special session on Genomic Penetrance on 18 March 2025, featuring Jasmine Gratton, Anwar Chahal, Catherine Chronaki, and Philippe Page.

This prestigious forum provides an excellent platform for networking, dynamic discussions, and multi-stakeholder engagement.

NextGen is funded by the EU Horizon Europe programme, Grant Agreement nr. 101136962.